Integral DiagnosticsASX:IDX -0.50%73 Operating Margin % is 8.47% as of Dec. 2025, which is 36% below its 10-year median of 13.24. GuruFocus rates ASX:IDX with a GF Score™ of 73/100 and a GF Value™ of A$2.78 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Integral Diagnostics ranks better than 67.16% on this metric.
Integral Diagnostics Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -13.1%.
The historical rank and industry rank for Integral Diagnostics's Operating Margin % or its related term are showing as below:
ASX:IDX'
s Operating Margin % Range Over the Past 10 Years
Min: 8.89 Med: 13.24 Max: 17.21
Current: 9.18
ASX:IDX's Operating Margin % is ranked better than 67.16% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: -3.195
vs ASX:IDX: 9.18
Integral Diagnostics's 5-Year Average Operating Margin % Growth Rate was -13.10% per year.
Integral Diagnostics (ASX:IDX) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Integral Diagnostics Operating Margin % Related Terms
Integral Diagnostics Operating Margin % Historical Data
* Premium members only.
The historical data trend for Integral Diagnostics's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:IDX vs TMO, DHR, IDXX: Operating Margin % Comparison
For the Diagnostics & Research subindustry, Integral Diagnostics's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integral Diagnostics Operating Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Integral Diagnostics's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Integral Diagnostics's Operating Margin % falls into.
Integral Diagnostics Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Integral Diagnostics's Operating Margin % for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integral Diagnostics (ASX:IDX) has a Operating Margin % of 8.47% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Integral Diagnostics and its competitors. This is 36% below median its historical median of 13.24. Over the past decade, Integral Diagnostics' Operating Margin % has ranged from 8.89 to 17.21. According to the industry distribution chart, Integral Diagnostics ranks #67 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 32.8%.
Is Integral Diagnostics' Operating Margin % too high?
Integral Diagnostics' current Operating Margin % of 8.47% is 36% below median its 10-year median of 13.24. Over the past 10 years, this metric has ranged from a low of 8.89 to a high of 17.21. Based on the distribution chart, Integral Diagnostics ranks #67 out of 204 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Integral Diagnostics has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Integral Diagnostics' Operating Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Integral Diagnostics ranks #67 out of 204 companies for Operating Margin %. This puts Integral Diagnostics in the upper half of its industry. Historically, Integral Diagnostics' own Operating Margin % has ranged from 8.89 to 17.21 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Diagnostics & Research company?
A good Operating Margin % depends on the Medical Diagnostics & Research industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Integral Diagnostics and its competitors. Integral Diagnostics's current Operating Margin % is 8.47%, which is 36% below median its own 10-year median of 13.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integral Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Integral Diagnostics (ASX:IDX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$2.78, compared to a current price of A$2.00 — trading 28.1% below its estimated fair value. The current Operating Margin % is 8.47%, which is 36% below median its 10-year median of 13.24. Integral Diagnostics' overall GF Score™ is 73/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Integral Diagnostics (ASX:IDX), the current Operating Margin % is 8.47% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integral Diagnostics (ASX:IDX) Overvalued in 2026?
Based on GuruFocus' analysis, Integral Diagnostics stock appears to be undervalued.
The current stock price of A$2.00 is trading 28.1% below its estimated GF Value™ of A$2.78.
GuruFocus considers Integral Diagnostics to be Modestly Undervalued.
Key valuation signals for ASX:IDX:
Operating Margin %: 8.47% (36% below median its 10-year median of 13.24)
GF Value™: A$2.78 vs. price of A$2.00 (28.1% below fair value)
No single metric tells the full story. See the ASX:IDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integral Diagnostics is a major Australian diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.
73GF Score
Get the complete analysis for ASX:IDX
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:IDX has been successfully added to your 
